omniture
STANDIGM

Latest News

Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case

SEOUL, South Korea, Dec. 19, 2023 /PRNewswire/ -- Standigm , a compa...

2023-12-19 22:00 1262

Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week

SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- On September 5th, 2023 Standigm, a company using...

2023-09-12 21:00 1224

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Companies will identify novel therapeutic targets using Standigm's explainable AI and Nashville Bio...

2023-08-10 21:07 1252

Standigm announces Younsung Choo as chief executive officer

Former LG life Sciences exec and long-time Standigm advisor brings extensive experience in pharmace...

2023-04-13 00:07 1831

Standigm and Institut Pasteur Korea Identify Lead Compounds for Resistant Tuberculosis Thanks to Right Foundation Grant

Research achievements enabled by a combination of advanced AI platforms, research capabilities, an...

2023-04-05 00:07 2152

Standigm cited as 'Top 10 Generative AI-based startup based on VC Investment, 2019-2021' in Gartner® report

SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- Standigm , a compan...

2023-01-05 22:00 1571

Standigm Synthetic Research Center successfully accelerates drug discovery in its first year

Lab uniquely enables collaboration between chemical and AI researchers SEOUL, South Korea, Nov. 16,...

2022-11-17 08:45 2502

STANDIGM TO ATTEND BIO-EUROPE® 2022

Standigm will present AI-driven drug discovery technology at the conference CAMBRIDGE, England, Oct...

2022-10-19 01:50 1449

Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery

Veteran biotech and pharmaceutical executive will help company increase its growth and internationa...

2022-08-18 20:30 1592

STANDIGM WINS GOLD AND BRONZE STEVIE® AWARDS IN 2022 INTERNATIONAL BUSINESS AWARDS®

Winners to Be Celebrated During Event in London on 15 October SEOUL, South Korea, Aug. 16, 2022 /PR...

2022-08-16 20:30 2499

Standigm Signs MOU with Merck Korea for AI drug Discovery Research

- Merck's retrosynthesis AI software 'SYNTHIA™ retrosynthesis software' accelerates Standigm's synt...

2022-06-09 14:46 1456

Standigm Signs MOU with Merck Korea for AI drug Discovery Research

- Merck's retrosynthesis AI software SYNTHIA™ accelerates Standigm's synthesis capability SEOUL...

2022-06-01 21:00 2120

Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow ...

2021-11-30 21:30 1407

Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery

SEOUL, South Korea, Nov. 8, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow a...

2021-11-09 10:47 1795

Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease

SEOUL, South Korea, Nov. 3, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow a...

2021-11-03 21:00 1373